Cargando…
Cancer risks among BRCA1 and BRCA2 mutation carriers
BRCA1 and BRCA2 mutations increase breast and ovarian cancer risks substantially enough to warrant risk reduction surgery, despite variable risk estimates. Underlying this variability are methodological issues, and also complex genetic and nongenetic effects. Although many modifying factors are unid...
Autores principales: | Levy-Lahad, E, Friedman, E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360226/ https://www.ncbi.nlm.nih.gov/pubmed/17213823 http://dx.doi.org/10.1038/sj.bjc.6603535 |
Ejemplares similares
-
The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
por: Iqbal, J, et al.
Publicado: (2012) -
Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers
por: Antoniou, Antonis C, et al.
Publicado: (2006) -
UK BRCA mutation testing in patients with ovarian cancer
por: George, Angela
Publicado: (2015) -
BRCA mutated pancreatic cancer: A change is coming
por: Rosen, Michael N, et al.
Publicado: (2021) -
BRCA mutations and gastrointestinal cancers: When to expect the unexpected?
por: Maccaroni, Elena, et al.
Publicado: (2021)